214 related articles for article (PubMed ID: 19690525)
1. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis.
Ebert EC; Geng X; Bajpai M; Pan Z; Tatar E; Das KM
Am J Gastroenterol; 2009 Dec; 104(12):2996-3003. PubMed ID: 19690525
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Ebert EC; Geng X; Lin J; Das KM
Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune response against tropomyosin isoform 5 in ulcerative colitis.
Taniguchi M; Geng X; Glazier KD; Dasgupta A; Lin JJ; Das KM
Clin Immunol; 2001 Dec; 101(3):289-95. PubMed ID: 11726221
[TBL] [Abstract][Full Text] [Related]
4. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis.
Biancone L; Palmieri G; Lombardi A; Colantoni A; Tonelli F; Das KM; Pallone F
Am J Gastroenterol; 2003 Dec; 98(12):2719-26. PubMed ID: 14687823
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity against human tropomyosin isoforms in ulcerative colitis: localization of specific human tropomyosin isoforms in the intestine and extraintestinal organs.
Mirza ZK; Sastri B; Lin JJ; Amenta PS; Das KM
Inflamm Bowel Dis; 2006 Nov; 12(11):1036-43. PubMed ID: 17075344
[TBL] [Abstract][Full Text] [Related]
6. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis.
Geng X; Biancone L; Dai HH; Lin JJ; Yoshizaki N; Dasgupta A; Pallone F; Das KM
Gastroenterology; 1998 May; 114(5):912-22. PubMed ID: 9558279
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.
Onuma EK; Amenta PS; Ramaswamy K; Lin JJ; Das KM
Clin Exp Immunol; 2000 Sep; 121(3):466-71. PubMed ID: 10971512
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
9. Tropomyosins in human diseases: ulcerative colitis.
Das KM; Bajpai M
Adv Exp Med Biol; 2008; 644():158-67. PubMed ID: 19209821
[TBL] [Abstract][Full Text] [Related]
10. Molecular mimicry may contribute to pathogenesis of ulcerative colitis.
Kovvali G; Das KM
FEBS Lett; 2005 Apr; 579(11):2261-6. PubMed ID: 15848155
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives.
Biancone L; Monteleone G; Marasco R; Pallone F
Clin Exp Immunol; 1998 Aug; 113(2):198-205. PubMed ID: 9717968
[TBL] [Abstract][Full Text] [Related]
12. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
13. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis.
Biancone L; Mandal A; Yang H; Dasgupta T; Paoluzi AO; Marcheggiano A; Paoluzi P; Pallone F; Das KM
Gastroenterology; 1995 Jul; 109(1):3-12. PubMed ID: 7797027
[TBL] [Abstract][Full Text] [Related]
14. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
15. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
[TBL] [Abstract][Full Text] [Related]
17. Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC).
Ueki T; Mizuno M; Uesu T; Kiso T; Nasu J; Inaba T; Kihara Y; Matsuoka Y; Okada H; Fujita T; Tsuji T
Clin Exp Immunol; 1996 May; 104(2):286-92. PubMed ID: 8625522
[TBL] [Abstract][Full Text] [Related]
18. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.
Halstensen TS; Mollnes TE; Garred P; Fausa O; Brandtzaeg P
Gut; 1992 Jul; 33(7):902-8. PubMed ID: 1379568
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis.
Khoo UY; Bjarnason I; Donaghy A; Williams R; Macpherson A
Gut; 1995 Jul; 37(1):63-70. PubMed ID: 7672683
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
